Pyrrolotriazine compounds as tam inhibitors
US9981975B2 · kind B2 · utility
14Cited by
12References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 27, 2017 |
| Grant date | May 29, 2018 |
| Priority date | — |
| Expiry date | Mar 27, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D403/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This application relates to compounds of Formula I:or pharmaceutically acceptable salts thereof, which are inhibitors of TAM kinases which are useful for the treatment of disorders such as cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.